Login / Signup

Low booster uptake in cancer patients despite health benefits.

Jane C FigueiredoJulia LevySo Yung ChoiAlexander M XuNoah M MerinOmid HamidTucker LemosNathalie NguyenMaimoona NadriAlma GonzalezSimeon MahovJustin M DarrahJun GongRonald L PaquetteAlain C MitaRobert A VescioSarah J SalvyInderjit MehmiAndrew E HendifarRonald NataleWarren G TourtellotteV Krishnan RamanujanCarissa A HuynhKimia SobhaniKaren L ReckampAkil A Merchant
Published in: medRxiv : the preprint server for health sciences (2023)
COVID-19 booster vaccinations increase antibody levels and maintain T-cell responses against SARS-CoV-2 in patients receiving various anti-cancer therapiesBooster vaccinations reduced all-cause mortality in patientsA significant proportion of patients remain unboosted and strategies are needed to encourage patients to be up-to-date with vaccinations.
Keyphrases
  • sars cov
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • healthcare
  • prognostic factors
  • mental health
  • risk assessment
  • patient reported outcomes
  • social media